Altimmune to participate at two upcoming investor conferences

Gaithersburg, md., may 31, 2023 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that members of the company's management team will participate and be available for 1x1 meetings at the following investor conferences:

ALT Ratings Summary

ALT Quant Ranking